Industry Roundup: Restoring Access Legislation, Adulterated Ayurvedics, UK Claims Enforcement
This article was originally published in The Tan Sheet
Executive Summary
Mylan, Perrigo more candid in hostile takeover comments; House committee clears Restoring Access bill; UK enforces on supplement ad claims.
You may also be interested in...
Unfettered OTC Purchasing With Pre-Tax Savings Tops CHPA Goals In 2015
CHPA is optimistic 2015 is the year “common sense” will restore OTC eligibility for health spending accounts. Speaking on the group’s priorities, President and CEO Scott Melville said CHPA will work to improve the OTC monograph system and to curb cough medicine abuse.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.